221 related articles for article (PubMed ID: 8588672)
1. Ototoxicity of ear drops: a clinical perspective.
Linder TE; Zwicky S; Brändle P
Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
[TBL] [Abstract][Full Text] [Related]
2. Safety of ototopical antibiotics.
Welling DB; Forrest LA; Goll F
Laryngoscope; 1995 May; 105(5 Pt 1):472-4. PubMed ID: 7760659
[TBL] [Abstract][Full Text] [Related]
3. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
4. Safety of topical ear drops containing ototoxic antibiotics.
Rakover Y; Keywan K; Rosen G
J Otolaryngol; 1997 Jun; 26(3):194-6. PubMed ID: 9176804
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of ototopical drugs: animal modeling.
Morizono T
Ann Otol Rhinol Laryngol Suppl; 1990 Jun; 148():42-5. PubMed ID: 2112363
[TBL] [Abstract][Full Text] [Related]
6. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
7. Ototoxicity after use of neomycin eardrops is unrelated to A1555G point mutation in mitochondrial DNA.
Yamasoba T; Tsukuda K
J Laryngol Otol; 2004 Jul; 118(7):546-50. PubMed ID: 15318963
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
Roland PS; Pien FD; Schultz CC; Henry DC; Conroy PJ; Wall GM; Garadi R; Dupre SJ; Potts SL; Hogg LG; Stroman DW;
Curr Med Res Opin; 2004 Aug; 20(8):1175-83. PubMed ID: 15324520
[TBL] [Abstract][Full Text] [Related]
9. Topical otic antibiotics: clinical cochlear ototoxicity and cost consideration.
Berenholz LP; Burkey JM; Farmer TL; Lippy WH
Otolaryngol Head Neck Surg; 2006 Aug; 135(2):291-4. PubMed ID: 16890085
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity of an ototopic preparation--experimental results and clinical facts.
Halama AR; Wright CG; Meyerhoff WL
Acta Otorhinolaryngol Belg; 1991; 45(3):279-82. PubMed ID: 1950546
[TBL] [Abstract][Full Text] [Related]
11. Experimental evidence of ototoxicity of ear drops. A review of the literature.
Kuhweide R
Acta Otorhinolaryngol Belg; 1995; 49(3):293-8. PubMed ID: 7484150
[TBL] [Abstract][Full Text] [Related]
12. Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream.
Thomas SP; Buckland JR; Rhys-Williams SR
J Laryngol Otol; 2005 Jan; 119(1):48-50. PubMed ID: 15807966
[TBL] [Abstract][Full Text] [Related]
13. The development of antibiotic resistant organisms with the use of ototopical medications.
Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG
Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367
[TBL] [Abstract][Full Text] [Related]
14. Ototoxicity of ear drops in patients suffering from chronic otitis media.
Podoshin L; Fradis M; Ben David J
J Laryngol Otol; 1989 Jan; 103(1):46-50. PubMed ID: 2537872
[TBL] [Abstract][Full Text] [Related]
15. [Topically induced ototoxicity].
Federspil P
HNO; 1984 Feb; 32(2):81-3. PubMed ID: 6706705
[TBL] [Abstract][Full Text] [Related]
16. Ototoxicity of ototopical antibiotic drops in humans.
Matz G; Rybak L; Roland PS; Hannley M; Friedman R; Manolidis S; Stewart MG; Weber P; Owens F
Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S79-82. PubMed ID: 15054365
[TBL] [Abstract][Full Text] [Related]
17. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea.
Poetker DM; Lindstrom DR; Patel NJ; Conley SF; Flanary VA; Link TR; Kerschner JE
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1294-8. PubMed ID: 17178938
[TBL] [Abstract][Full Text] [Related]
18. A group III steroid solution without antibiotic components: an effective cure for external otitis.
Emgård P; Hellström S
J Laryngol Otol; 2005 May; 119(5):342-7. PubMed ID: 15949095
[TBL] [Abstract][Full Text] [Related]
19. [Efficiency of otoph and polydex ear drops in otitis treatment].
Luchikhin LA; Magomedov MM; Gorbacheva VA
Vestn Otorinolaringol; 1999; (4):32-4. PubMed ID: 10453233
[No Abstract] [Full Text] [Related]
20. Prevalence of middle ear pathologies in children with bilateral sensorineural hearing loss.
Abou-Elhamd KE; Moussa AE; Soltan MA
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1081-4. PubMed ID: 16406124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
